In this video, Laura T. Safar, MD, gives an overview of psychotropic treatment classes, their uses in the management of neuropsychiatric disorders among patients with multiple sclerosis, and important...
In this video, Dr Hudesman, from NYU Langone Health, highlights the current literature on the management of inflammatory bowel disease with underlying malignancy.
He talks about how to make progress in the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. He recently spoke about this topic at the 21st Annual Harvard Nutrition and...
In this video, Dr Krysko discusses the findings from her study on the real-world effectiveness of newer vs injectable disease-modifying therapies among pediatric patients with multiple sclerosis.
Co-Chair Edward Shahady, MD, FAAFP, ABCL, interviews Kevin Peterson, MD, MPH, on what happens to Beta Cells after 3 years of GLP-1 administration, compared with insulin.
